TriSalus Life Sciences Warrant
TLSIW
29 hedge funds and large institutions have $2.59M invested in TriSalus Life Sciences Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
1% more capital invested
Capital invested by funds: $2.55M → $2.59M (+$36.1K)
0% more funds holding
Funds holding: 29 → 29 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$988 |
| 2 |
ETH
Exos TFP Holdings
New York
|
+$693 |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$83 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Nomura Holdings
Tokyo,
Japan
| $1K | – | – | – |
|
|
OMC
27
Old Mission Capital
Chicago,
Illinois
| $935 | +$83 | +1,219 | +11% |
|
|
ETH
28
Exos TFP Holdings
New York
| $767 | +$693 | +10,222 | New |
|
|
FSI
29
Flow State Investments
Chicago,
Illinois
| $752 | +$680 | +10,033 | New |
|
30
UBS Group
Zurich,
Switzerland
| $4 | -$304 | -4,480 | -99% |
|
|
BCM
31
Basso Capital Management
Stamford,
Connecticut
| – | -$3K | -52,468 | Closed |
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1K | -20,661 | Closed |
|
|
OCAM
33
Owl Creek Asset Management
New York
| – | -$1K | -13,333 | Closed |
|
TLSIW Hedge Fund Activity: Q4 2022 in Review
29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2022, worth a combined $2.59M — up 1.4% from $2.55M a quarter earlier.
Fund positioning in TLSIW was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was HRT Financial, adding an estimated $988. The largest seller was Islet Management, cutting an estimated $6.7K.
- 29 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $2.59M of TriSalus Life Sciences Warrant stock for Q4 2022, up 1.4% quarter-over-quarter.
- 3 funds opened new TriSalus Life Sciences Warrant positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q4 2022 was HRT Financial, an estimated $988 added.
- The largest TriSalus Life Sciences Warrant seller in Q4 2022 was Islet Management, an estimated $6.7K sold.
Based on aggregated 13F filings for Q4 2022.